A donation of 200 Tracer microchips by Bayer is helping to save one of the world's largest and rarest species of frog against extinction. A deadly fungal disease, responsible for decimating global amphibian populations, is threatening the last known wild population of the 'mountain chicken' frog (Leptodactylus fallax).
The eastern Caribbean island of Montserrat is the last global stronghold for this species - known locally as mountain chicken due to its taste. As recently as 2002, chytridomycosis wiped out the majority of mountain chicken frogs on the island of Dominica. Recent tests on dead frogs found in the west of Montserrat have confirmed the presence of this disease.
The Durrell Wildlife Conservation Trust has been working in Montserrat since the early 1990s to support the local government in the protection of the island's vast biodiversity. The mountain chicken has been an important species, and Durrell holds the largest safety net population at its Jersey headquarters.
In response to the positive identification of the disease, Durrell has launched an emergency plan to rescue healthy frogs and put in place longer treatment and management plans for the protection of the species.
Bayer's donation of 200 Tracer microchips will be used to individually identify the captive mountain chickens held by Durrell to help manage a breeding programme. Durrell is also testing the feasibility of treating the frogs with antifungals in their natural habitat, and the use of the donation of microchips will be essential to allow individual frogs to be monitored to assess the outcomes of treatment regimes.
Durrell's head of veterinary services, Javier López, has worked with mountain chickens for a number of years, and explains that the disease could very quickly wipe out the species. Captive populations of healthy frogs, such as the one in Jersey, could be used to initiate re-introductions back to the wild or in disease-free areas.
One of the most significant changes has been the introduction of video consultations which have allowed clinicians to continue to see patients in need whilst maintaining social distancing.
At the start of lockdown, Davies split many of its service teams into two, which alternate weekly between consulting remotely from home and operating on-site.
The practice says that continual communication between the two teams has enabled the efficient triage of referred cases, whilst the ongoing management of less urgent cases is discussed with clients and referring vets until the patient can be seen on site.
Davies says the new system has been particularly effective for its orthopaedics service, which has seen an increasing demand for video consultations.
Jan Janovec, European Specialist in Small Animal Surgery and Head of orthopaedics said: "Every challenge is an opportunity. The current adverse circumstances are forcing us to re-evaluate the ways we have traditionally worked, and I believe that this “audit” will result in new and better ways of delivering care to our patients.
“Despite lockdown cats continue to explore outdoors and get injured and dogs continue to chase squirrels and birds! Puppies and small dogs continue to get sat on or stepped on by their family members and so they keep us busy mending broken legs, fixing dislocated joints, and so on.”
Once lockdown has ended Jan says that he and his team intend to review what they have learnt and re-evaluate all aspects of the orthopaedic service process to make the clinician, client, patient and referring vet interactions even better.
The grants, which are for up to £3,500 per annum, are for students embarking on a gateway or main veterinary degree course, possibly as a second degree.
Amber Cordice was an early recipient of a Quadstar Foundation grant which she has had for the last four years.
She'd always wanted to be a vet, but didn't quite get the A level grades, so she took an undergraduate Zoology degree and got a first.
She was then awarded a place at Harper and Keele Veterinary School, but just didn't have the money because there is no finance for second degrees.
So the enterprising student set up a 'Go Fund Me Page' which got reported by VetSurgeon.org News, which is how Nick found out about her challenges and the rest is history.
Except not quite, because then Alicia Guarnieri (pictured) found herself in a similar position.
She'd completed a degree in Bioveterinary Science before starting a vet degree at the University of Bristol.
She said: “I’d managed to save up prior to being offered my place but when Covid hit, most of it went on rent.
"Like Amber, I decided to defer my place. I looked everywhere for grants, spending hours sifting through guides and asking all the vets I knew, but it all came to a dead end."
But then she came across Amber's story on VetSurgeon.org and, through her, found out about the Quadstar Foundation which awarded her with a grant which covers over a third of her tuition costs.
Alicia added: “Finances are a huge barrier to students taking a second degree, particularly after tuition fees increased.
"There are many of us in the same boat, and sadly many who turn down their place solely due to cost.
"Nick and the Quadstar Foundation are truly changing people’s lives by offering this support.
"Having thought I would never get to this point, I can’t wait to qualify next year and finally become a vet, and I am forever grateful for the help The Quadstar Foundation has provided me.”
Quadstar's latest grantee is Raluca Magadan, a veterinary nurse from Ireland, who is now on the accelerated graduate course at Bristol University.
She said: “Doing a second degree was never going to be easy.
"However, through help from family and locum vet nurse work, I managed to afford my first three years of vet school and made it into final year.
"This is where the difficulty came, as I had to more than forty hours per week of unpaid rotations work, plus clinical EMS during the holiday breaks, which made it very hard for me to earn the money I needed to afford my final year.
"At times it meant I had under £100 to survive an entire month on, which became a big physical and mental challenge.
“That’s when the Quadstar Foundation stepped in and took a weight off my shoulders by helping to pay off my outstanding university fees and providing some financial security in my final months.
"This has been a huge relief and allowed me to finally enjoy my last year at Bristol.
"I can’t thank everyone at the charity enough.”
In addition to funding and mentoring, The Quadstar Foundation helps its grantees with everything from job applications to revision techniques, as well as any mental health crises and helping them to find a place to live.
Nick, who also runs a property and acquisitions company and Animus Surgical, a pet and vet supplies company, said: “Having worked as a vet for many years before setting up my businesses, I have great industry connections and knowledge.
"So, I’m in the privileged position of being able to help committed students to seize the career opportunities they deserve.”
“My main commercial motivation now is to be able to maintain the funding streams required for these grants.
"It’s surprisingly hard to fundraise for individuals.
"That’s why Animus Surgical has just committed to donating 15% of its profits to the Quadstar Foundation.”
He added: “It’s an enormous privilege to support these inspiring young vets who have had such a hard slog to get past the ever-increasing barriers they face. Barriers that back in our day didn’t exist.”
What a lovely story. VetSurgeon.org is proud to have played a tiny little part in it and wishes Amber, Alicia and Raluca every success in their future careers. And hats off to Nick.
www.quadstar.org
The Royal Veterinary College has carried out the first ever open-heart surgery to treat a stenotic tricuspid valve in a dog.
The three-year-old Labrador, Mabel, suffered from congenital tricuspid dysplasia. She was referred to cardiology specialists at RVC Small Animal Referrals where her tricuspid valve was found to be completely fused in the middle, with just two very small openings for her blood to flow through.
In a procedure that took a little over an hour, the RVC team examined and worked on the valve. The College reports that Mabel’s surgery was a success and her stenosis was relieved.
Mabel was subsequently found to have a moderate amount of regurgitation into the right atrial chamber, but after a few more days of additional monitoring at the RVC she was able to return home.
The surgery was carried out by Professor of Small Animal Surgery Dan Brockman at the Queen Mother Hospital for Animals. He was assisted by a team of RVC specialists to provide pre and post-operative care, including a perfusionist, a team of three anaesthetists, two surgery nurses, three surgeons and a cardiology veterinary specialist-in-training. In addition, Professor of Veterinary Cardiology Virginia Luis Fuentes and veterinary specialist-in-training Dr Rosie Payne were members of the Cardiology Service’s investigation into Mabel’s condition.
RVC students were also involved in the Mabel’s initial examinations at the hospital, providing them with an insight into the procedure. The examinations included cardiac ultrasound using the newest generation of cardiac ultrasound equipment, which is able to capture 3D and 4D images. The new ultrasound scanner was funded in part by the RVC’s charity, the Animal Care Trust.
After the surgery, the emergency and critical care (ECC) team and the Cardiology Service took over Mabel’s care, with Professor Brockman remaining involved. This saw up to four senior ECC clinicians, a number of veterinary specialists-in-training and half a dozen highly trained ECC technicians working in shifts around the clock to care for Mabel and ensure a good recovery.
According to the RVC, there have been previous attempts by veterinary surgeons to open stenotic valves with balloon valvuloplasty. However, because it is very difficult to tear the stenotic valve, this approach has not proved very successful. There is also a high risk when putting canines onto bypass. Canines have fragile blood vessels, and cannulae need to be inserted into several of these vessels, creating a danger that a major vessel tears.
Commenting on why the RVC team decided to perform this procedure at this point, and on Mabel, Dan said: "Lots of things fed into this decision. First and foremost, we had a patient whose pathology made surgery the best solution. I explained to the owner and was very honest that this procedure would be really breaking new ground. Based on what the human paediatric cardiac surgeons will do, and our limited experience of balloon-valvuloplasty suggests this is the best approach for these dogs
"The operation itself is risky, much worse than most other operations. In our hands, for this type of disease, we have about an 80% chance of getting them through the procedure. The owner has to gamble what life the dog has left against the promise of a more normal quality of life and life-span following the operation."
In relation to Mabel’s prognosis if the surgery had not been undertaken, Professor Luis Fuentes said: "It is likely that the signs of right-sided heart failure would have been more difficult to control. Her ability to exercise would have become less and less, and she would have also been at risk of having abnormal heart rhythms associated with the enlargement of the right atrium. Generally we expect them to develop more and more signs as the disease progresses. These are difficult cases to manage on a long-term basis with drugs. Her life expectancy would have been substantially reduced.
"I thought Mabel was almost a perfect candidate to have the procedure here as Dan has a lot of experience replacing tricuspid valves in dogs with tricuspid dysplasia. In those cases there is usually leaking, but Mabel’s case was unusual in that she has minimal leaking and she was most affected by the stenosis. That means you may not have to implant any additional valve structure."
Speaking two weeks after the operation, owner Annabelle Meek, from Melton Mowbray, said: "Mabel has just come back in from wandering around the perimeter of my garden for the first time since before the operation. It’s more than half an acre and she has been ambling around happily following a scent.
"I would like to thank absolutely everybody. It’s been an enormous team effort on all sides. Every single person I met at the RVC, from the man on the gate to all the hospital staff, was so friendly. After she came home Dan Brockman phoned me every day to see how she was doing. The RVC should be very proud of what they have done for Mabel."
Caused by the mite Psoroptes ovis, sheep scab was notifiable in the UK until 1992, after which a voluntary reporting scheme was put in place in England and Wales. Sheep scab was made notifiable again in Scotland in 2010.
The study was suggested by Emily Gascoigne MRCVS of Synergy Vets, who noticed that hers was one of the few practices that appeared to be voluntarily reporting cases in England.
She said: "It’s been observed that that farmers can feel ‘judged’ when sheep scab appears in their flock and the impulse to keep it hidden may hold back efforts to control it.
“The results will help to quantify the problem but we are also tackling the other side of the coin by trying to make sheep scab less of a taboo. The potential for contiguous infection from one farm to the other means that forewarned is forearmed.
"Farmers often blame themselves when their sheep get scab which although it can result from a failure of biosecurity at boundaries or during quarantine, can also be brought in on people, deliveries or equipment. Then there are real worries about whether that will affect the saleability of their stock or their relationship with their farming neighbours. We want to encourage vets and farmers to start the conversation and to start actively testing for sheep scab.”
Around 40 practices within the XLVets community are now taking part in the study. In addition to contributing to the survey, participating practices will also be sharing information with farmers about the importance of testing for sheep scab.
The initiative is being supported by Bimeda UK, which provides an online Sheep Scab Academy to help veterinary surgeons and SQPs stay up to date with best practice for sheep scab control. Bimeda UK’s Professional Services Vet Sharon Cooksey, said: "Bimeda has worked for many years to raise awareness and promote best practice in managing this awful disease, including supporting the launch and ongoing operation of the Biobest ELISA test, so this is an initiative we are happy to support.”
The survey has been running since the start of October and will continue for the next five months, with results expected around March 2021.
The Royal College of Veterinary Surgeons is calling for members to nominate veterinary surgeons and non-veterinary surgeons who merit the award of Honorary Associateship or Honorary Fellowship.
Honorary Associateships are awarded annually to people, not necessarily veterinary surgeons, by reason of their special eminence in, or special service to, the veterinary profession. Council has agreed that these should only be people ineligible for election as Honorary Fellows.
Honorary Fellowships can be awarded to up to three veterinary surgeons in any one year for their service to, or special eminence in, the cause of veterinary science.
Nominees for Honorary Fellowships must be members of the RCVS and have been a member, or held a registrable qualification, for at least 20 years.
All nominations need to include the particular reasons why the honour/award should be conferred, along with supporting statements from two referees, at least one of whom must not be a working colleague of the person nominated.
Nominations must be received by the President, Dr Jerry Davies, by Friday, 2 September 2011.
Members may download the nomination form, or request it from the RCVS Executive Office (0207 202 0761 or executiveoffice@rcvs.org.uk).
Virbac has launched Inflacam, a meloxicam-based NSAID for the alleviation of pain in both acute and chronic musculo-skeletal disorders in dogs and horses.
Inflacam is presented both as an oral suspension and as a chewable tablet for dogs. The suspension is available in 200ml, 100ml, 42ml and 15ml sizes with a measuring syringe provided. The tablets come in two sizes - 1 mg and 2.5 mg - and are available in packs of 100. It is available for horses as an oral suspension.
Virbac Product Manager Chris Geddes MRCVS, said: "Virbac is well known for launching innovative products in areas such as dermatology and reproduction but we also aim to support practices by offering tried and trusted practice 'standards' for everyday use. Inflacam fits this brief well - meloxicam is the most commonly-used NSAID in dogs and we are delighted to add it to our range."
For more information contact your territory manager or call Virbac on 01359 243 243.
Animalcare has announced the launch of Thiafeline (Thiamazole 2.5mg and 5mg) for the management of hyperthyroidism in cats.
An estimated 12% of UK cats over the age of nine suffer from hyperthyroidism², which could equate to almost 350,000 cats³. In one study, 92% of cats diagnosed with hyperthyroidism were stable after four weeks treatment (on the twice daily 2.5mg dosing) with thiamazole¹
Thiafeline is presented as a blister pack, which Animalcare says offers the benefits of easy dispensing, improved stock control and no nurse exposure during dispensing for increased safety in practice. This format also allows pet owners to monitor the dosage and quantities easily, for an uninterrupted course of medication.
Animalcare says that whilst many of the clinical signs for hyperthyroidism are easily recognised, it understands that diagnosis is not always straightforward. For this reason, the company has produced support materials for Thiafeline users including diagnosis best practice charts for use within practice and a pet owner awareness package for use in waiting rooms.
Beverley Hammond, Product Manager for Thiafeline said: "While initial signs associated with hyerperthyroidism can appear quite mild it is important for pet owners to understand that if left untreated the condition can lead to serious secondary complications. It's easy for owners to assume that the signs they are seeing are simply related to old age so our campaign will aim to increase the amount of owners bringing their cats for senior pet checks and also ensure that vets are following the best practice procedures to reach a definitive diagnosis."
References
The practice, which is part of the Linnaeus Group, achieved 'outstanding' status in diagnostic service, in-patient service and emergency and critical care service, after scoring above 80% in each area during the RCVS assessment.
Ian Monteith, managing director of Calder Vets, and also Paragon Veterinary Referrals; a new £5 million plus state-of-the-art referral centre being launched in Wakefield at the end of the year, said: "The team here at Calder take great pride in providing the highest possible level of care for our patients and their owners, often using cutting-edge techniques. We have some hugely experienced and talented professionals who always go the extra mile to ensure our patients and clients have the best possible experience.
"Our veterinary specialists and caring support teams, are totally committed to ensuring Calder Vets continues to provide outstanding standards and as such we are very proud to have achieved these additional accreditations by the Royal College of Veterinary Surgeons."
The webinars will be presented by specialists in their respective fields; small animal oncologist Sara Verganti and clinical pathologists Francesco Cian and Roberta Rasotto.
Each 30-minute session will focus on a specific aspect of MCT diagnostics followed by a multidisciplinary Q&A. The sessions, which all start at 7:30pm, are:
Dr Neil Mottram MRCVS, Technical Product Manager at Virbac said: "Mast cell tumours are the most common form of canine cutaneous neoplasia, although relatively simple to identify, knowing what diagnostic steps to take can be challenging. We believe this truly comprehensive bite size mini-series will provide vets with the confidence to navigate the diagnostic approach for their next MCTs."
For more information, contact your Virbac Territory Manager.
Under the previous system, complaints made about a veterinary surgeon or veterinary nurse would, at Stage One, be considered by a Case Examiner Group (CEG) which would determine if there was an arguable case of serious professional misconduct.
If the CEG found there was an arguable case, it would then refer it to Stage Two of the process for consideration by the Preliminary Investigation Committee.
The CEG stage of the process has now been replaced by Stage One Preliminary Investigation Committees which, rather than using the ‘arguable case’ threshold, will consider from the outset whether there is a realistic prospect that the alleged conduct constitutes serious professional misconduct and that there is sufficient evidence.
The new Stage One Preliminary Investigation Committees will comprise members of the professions and lay people, and will be assisted in their investigations by an RCVS Case Manager who will also be the first point of contact for those raising concerns, witnesses and respondents in the case.
Eleanor Ferguson, RCVS Registrar and Director of Legal Services, said: “By keeping to one consistent threshold for serious professional misconduct throughout the concerns investigation process, we hope that these changes will help to simplify our investigations while still ensuring that the process remains robust and thorough.
"We also hope that, in time and when the changes are fully bedded in, we may also see a swifter resolution to some cases, as concerns that may previously been referred on to Stage Two of the process can now be closed at Stage One.”
If a Stage One Preliminary Investigation Committee cannot close a case it will refer it on to a Stage Two Preliminary Investigation Committee.
This will gather additional information and evidence and then determine if there is a realistic prospect of finding serious professional misconduct and if it is in the public interest for the case to go to Stage Three - a full, public Disciplinary Committee hearing.
Eleanor added: “The introduction of these new stages is the first step in the programme of reform of our concerns investigation and disciplinary processes.
"Next year we will be looking to introduce our Charter Case Protocol which will be a way of resolving some less serious cases of alleged misconduct where it would not necessarily be in the public interest to hold a full Disciplinary Committee hearing.”
www.rcvs.org.uk/concerns
New research published in the Equine Veterinary Journal (EVJ) has shown that the use of standing sedation to repair lower limb fractures in racehorses produces similar results to surgery performed under a general anaesthetic, but with the advantages of less surgical complexity, time, cost and risk.
The study Short and long term results following standing fracture repair in 34 horses was conducted by Richard Payne and Polly Compston at Rossdales Equine Hospital1.
Standing fracture repair in the horse is a relatively new surgical procedure with very little follow-up data available. Treatable fractures sustained by racehorses in the UK have traditionally been repaired under general anaesthesia but it is well known that this carries an increased risk of anaesthetic-related death compared with other elective surgical procedures. However, despite the substantial increase in the number and type of surgical procedures performed under standing sedation over the past decade there has previously been very little work undertaken on standing fracture repairs.
The study looked at the case records of 34 Thoroughbred and Arab racehorses that had a lower limb fracture surgically repaired by one surgeon at Rossdales up until June 2011. The injuries included non-displaced fractures of the proximal phalanx, the third metacarpal bone and the third metatarsal bone, all of which are relatively common fracture sites in racehorses. Hospital records, owner and trainer telephone questionnaires and website research were used to evaluate follow-up. The short and long-term results were similar to those of horses undergoing repair of comparable fracture configurations under general anaesthesia, with 20 of the horses returning to racing within an average of 226 days.
This early research indicates potential for tangible benefits, including avoidance of the inherent risks of general anaesthesia as well as a reduction in surgical complexity and associated costs, leading the way for future research into larger cohorts of horses.
EVJ's Editor Celia Marr said: "The recent fatalities at the Grand National highlight that it is critical that the equine veterinary research community strives to reduce the prevalence of fractures in our racehorses. We also need to continue to seek better ways of treating those horses that do develop fractures and, while not every fracture will be amenable to this approach, this study is an important first step towards treating some of the non-displaced fractures that occur in racehorses without the need for anaesthesia."
1Short and long term results following standing fracture repair in 34 horses Richard Payne and Polly Compston, Equine Veterinary Journal ISSN 0425-1644 DOI: 10.1111/j.2042-3306.2012.00569.x
A total of 8,234 votes were cast in this year’s election, a turnout of 25.5%. The College says the previous highest turnout recorded this century was 22.8%, and it thinks this year's result may even be an all-time record.
It is unclear how much the results were influenced by VetSurgeon.org's reporting of the candidates standing for election, but in another first, Niall Connell was later seen sporting a t-shirt displaying the story: "Arlo said I'm 'by all accounts, something of a national treasure'. Had to do it. Got the T Shirt."
You're welcome, Niall. And huge congratulations to Jo Dyer, who is such a passionate advocate for coal face vets, and to Linda Belton too.
At the other end of the results, isn't it staggering that there are as many as 422 MsRCVS who are prepared to vote for a single non-issue candidate based the other side of the world. Who are you? Why do you do it? I mean, one can understand a few people voting for the Monster Raving Loony Party out of the general population numbering millions. But 5% of a small, highly educated and qualified profession? What on earth is that about?
The full results, in order of number of votes, are:
Niall Connell – 3,766 votes (re-elected)
Linda Belton – 3,581 votes (elected)
Jo Dyer – 3,146 votes (re-elected)
John Innes – 2,716 votes
Kate Richards – 2,283 votes
Tim Greet – 2,280 votes
Peter Robinson – 1,791 votes
John Davies – 507 votes
Tom Lonsdale – 422 votes
Eleanor Ferguson, RCVS Registrar and Returning Officer for the election, said: "Congratulations to Niall and Jo for being re-elected to Council and congratulations also to Linda who we look forward to welcoming to Council at this year’s Royal College Day on Friday 12 July. I would also like to thank Kate, Tim and Peter for their contributions during their time on Council and give my commiserations to them and the other candidates who were unsuccessful this year.
"I was delighted to see that, this year, we had over a quarter of those eligible to vote doing so which means both a record number of votes and a record turnout – it seems this was assisted by our email reminders which, each time they were sent out, lead to a significant boost in uptake.
"However, we will not rest on our laurels and will continue to think about how we can further improve engagement in the election process and turnout for subsequent years."
The results of the election will be declared formally at this year’s Royal College Day – the College’s Annual General Meeting and awards ceremony – which takes place at the Royal Institute of British Architects on Friday 12 July 2019 where the successful candidates will also start their new four-year terms.
No election to Veterinary Nursing Council was held this year due to the fact that there were only two candidates – Liz Cox and Jane Davidson – standing for the two elected places. Both Liz and Jane will take up their three-year terms at Royal College Day.
HMRC has published advice concerning the forthcoming increase in the rate of VAT, from 17.5% to 20% on Tuesday 4th January 2011.
From 4th January, you will need to charge the new 20% VAT rate on all standard-rated sales you make and all retail takings your receive.
The new VAT fraction for the 20 per cent rate is 1/6 (used to calculate the VAT element of standard-rated gross takings).
If your business issues VAT invoices, you must use the new 20 per cent rate for all VAT invoices you issue on or after 4 January, which are issued within 14 days (or longer period that has been agreed with HMRC) of you providing the goods or services.
Supplies that span the rate changeIf you supply goods or services before 4 January 2011, but issue a VAT invoice on or after that date, you can choose to charge VAT at 17.5 per cent.
Continuous supplies of servicesFor a contract that started before 4 January you can choose to charge the old rate, 17.5 per cent, on services actually performed before 4 January, and the new rate of 20 per cent on the value of services actually performed after.
Reclaiming VATFrom 4 January 2011, you may receive VAT invoices with the new 20 per cent rate, as well as VAT invoices with the old 17.5 per cent rate for goods or services you bought before the rate changed. In such cases, you should claim back VAT at the rate shown on the invoice.
Completing a VAT returnThe deadlines for submitting VAT returns remain the same, so you should continue to submit VAT returns in the usual way - whether you send them monthly, quarterly or annually. For returns that span the change in rate, you will need to add together both the VAT on sales charged at 17.5 per cent and those charged at 20 per cent. You then put this total in box 1 of your VAT return.
Countering arrangements designed to take advantage of the VAT rate changeIn order to counter businesses taking advantage of the VAT rate change by making arrangements that aim to apply the 17.5 per cent VAT rate to goods or services to be delivered or performed on or after 4 January 2011, anti-forestalling legislation has been introduced. Further details of this can be found in the web link below.
Further informationHMRC has published detailed guidance on the rate change, which can be found at www.businesslink.gov.uk/vatratechange/.
Hill's Pet Nutrition is offering veterinary surgeons, vet students and nurses in the UK an opportunity to look round its Pet Nutrition Centre in Topeka, Kansas, via a live webcast to be delivered at 7pm on Tuesday 11th January 2011.
To join the webcast, which will last around 1.5 hours, go to http://www.fc-tv.com/webcast/keystone/hills/jan-11-11 and enter the password pnctour. This event is specifically for veterinary surgeons, veterinary students and veterinary nurses only.
Tim Dobbins, Associate Veterinary Affairs Manager said: "We look forward to our colleagues joining us for this special live webcast and hearing some of the latest thinking that explains the science behind some of our most exciting products."
The National Office of Animal Health has completed its annual review of its Code of Practice for the Promotion of Animal Medicines, and a number of changes will come into effect on 1st July 2011.
One change spells out the way antimicrobial medicines are promoted to farmers, with a firm emphasis on correct use and education.
Advertisers will be required to describe the condition the product is aiming to treat, and to promote an understanding of the treatment of the disease.
The phrase "use medicines responsibly" will always be included in text, making the voluntary strapline introduced in 2009 a formal part of the NOAH Code. As with all promotions to people other than prescribers, farmers will always be reminded to consult their veterinary surgeon.
Advertising text will always state clearly the name of the company and the brand being promoted, and promotion must not be designed to disguise its real nature.
Withdrawal periods for products will be stated, but these must not be unduly prominent and not in a font size greater than the body copy containing recommended dosage and species description.
The changes were proposed by NOAH within its formal response to the Veterinary Medicines Directorate's consultation on the Veterinary Medicines Regulation 2010. The Minister decided in December 2010 to continue to allow the advertising of antimicrobial veterinary products to farmers.
Phil Sketchley, NOAH Chief Executive, said: "Whilst welcoming the Government's decision in December not to further restrict the advertising of animal medicines, we feel that the industry should take a proactive role to ensure the system works properly. We believe it is important for farmers, who are legally responsible for the health and welfare of their animals and the food produced from them, to be aware of the medicines that are available to protect the health of their animals, and at the same time we want them to know that these medicines must be prescribed and used responsibly.
"The issue of antimicrobial resistance is one that affects us all. The way to promote best practice is through education by maintaining all lines of communication between farmers, vets, scientists and animal medicine producers.
"Antibiotics are essential for maintaining the health and welfare of all animals, but like any medicine they need to be used responsibly in order to maintain their effectiveness, and their availability for future generations."
The academy will consist of three modules which will be launched in 2021. Those who complete all three modules will receive certification from Bimeda, and some exclusive branded goodies.
The first module is titled Bimeda Trace Elements in Dairy Cow Fertility & Pregnancy and is available now on Bimeda’s e-learning portal: https://bimeda-learning.co.uk. This module also accounts for 1 hour 15 minutes of CPD and vets can download a certificate when they complete the module. The module has also been accredited with 9 AMTRA points.
In the coming months Bimeda says it'll add a second module focused on the role of trace element nutrition in lamb and calf growth, and a final module focused on the role of trace elements in sheep fertility and pregnancy.
Bimeda UK General Manager Mark Cokayne said: "Trace elements play a critical role in the health and fertility of ruminants, yet historically this area has been somewhat overlooked in formal animal health education.
"Our customers tell us that they would like a deeper understanding of areas such as trace element deficiencies, toxicities and interactions, and the impact of these on ruminant health and fertility. We are pleased to respond to this market demand with our new academy, which will provide veterinarians and SQPs with additional knowledge to help inform their conversations with farmers."
To sign up to either Bimeda’s online Nutrition Academy or the Sheep Scab Academy, visit https://bimeda-learning.co.uk
For more information, speak to your Bimeda territory manager or call Bimeda on 01248 725 400.
Speakers at the event include Toby Trimble, founder of Trimble Productions and a Specialist in Veterinary Anaesthesia and Analgesia, who will be advising on public speaking, Jonny Hughes, Diagnostic Imaging Specialist at Davies Veterinary Specialists, who will lead an interactive session reviewing radiographs from four real-life cases, and Emily Thomas, Specialist in Emergency and Critical Care at Dick White Referrals, who will appraise recent cases she has seen with her intern team.
Career experiences and advice will be shared by a live panel of current rotating interns.
In another session, residency programme directors from Linnaeus hospitals will offer their tips for successfully applying to a residency post.
Attendees will also be able to watch live sessions with interns and specialists performing diagnostics and procedures, including a laparoscopic spay at Eastcott and an echocardiographic exam at Anderson Moores.
Natasha Hetzel, Internship and Residency Manager at Linnaeus (pictured right), said: “This is the perfect opportunity to hear from peers who have completed a rotating internship, and watch live sessions showcasing the teaching that interns receive. Attendees will also receive support from experts on the internship application process, including a chance to book 1.1 sessions with internship directors for further advice.
“The event will also consider routes into residencies and becoming a specialist, as these are popular career routes for interns. However, an internship is also an excellent way to develop the skills and knowledge for a career in primary care.”
Attendees unable to join on the day can still register to watch the recorded sessions.
To register, visit: https://www.linnaeusgroup.co.uk/careers/internships/internships-explained.
European veterinary practitioners are to receive guidance on the appropriate use of the fluoroquinolone group of antibiotics in treating a wide range of common diseases in companion animals.
The advice has been drawn up by the REQUEST team, a multinational and multidisciplinary group of experts which met for the third time last November. Their recommendations have been designed to help ensure the continued availability of this class of antibiotics in both veterinary and human medicine.
The REQUEST initiative aims to achieve a consensus on when and how to prescribe fluoroquinolones, based on a detailed assessment of published scientific data by its panel of nine acknowledged international experts. Following earlier meetings in Lyon and Vienna they have reached a stage in this ongoing project in which they can offer specific guidance on the use of fluoroquinolones in treating three important conditions in dogs: pyoderma, bacterial diseases of the upper respiratory tract and lower urinary tract infections. They will also be offering guidance on the appropriate use of this class of antibiotics in cats to avoid the development of retinal toxicities, which may occasionally result from treatment with one particular fluoroquinolone drug, enrofloxacin.
The guidance will be presented in papers to be submitted to those scientific journals which will be easily accessible to veterinary practitioners throughout Europe. Further papers will be produced and translated into the main European languages giving guidance on fluoroquinolones use in other important bacterial conditions in dogs and cats.
In the later stages of the project, the team will be highlighting priorities for future research and will use its influence to encourage collaborative studies involving the animal health industry, practitioners, veterinary schools and other research institutions, which will validate and redefine the current recommendations. They will also advise on studies which may provide the information needed in those clinical areas where there is currently insufficient published data on which to base any practical advice, such as the use of fluoroquinolones in minor companion animal species.
The REQUEST initiative is supported by Vetoquinol, a global supplier of fluoroquinolone medicines to the veterinary community. Further support is provided by the healthcare consultancy StratAdviser Ltd, which gives assistance on methodology and other scientific matters and also guarantees the independence of the expert group.
The webinars will provide practical information to help manage renal cases, focusing on the importance of early diagnosis.
Led by feline medicine experts, Dr Tommaso Furlanello PhD ECVCP Dip and Dr Sarah Caney BVSc PhD DSAM(Feline) MRCVS, the webinars will provide practical information to help manage renal cases.
On 7th June, Tommaso's talk will address early diagnosis of feline chronic kidney disease (CKD) and recognition and management of its complications.
On the 28th, Sarah's talk will focus on supporting and communicating with cat owners around early diagnosis and achieving optimal long-term management.
The webinars will be available to watch live or as a recording after the event.
To register for the event, visit: https://purinaproplan-webinarseries.vfairs.com/
If you attend the live event, you'll have the chance to put questions to Sarah and Tommaso, but if you can't make it on the night, there'll be a recording afterwards.
Vita Referrals has been set up by Rob Quinn, an RCVS and EBVS Specialist in Small Animal Surgery, and Nick Blackburn and Stuart Cooke, both RCVS Advanced Practitioners in Small Animal Surgery.
They say that their aim is to ensure every pet owner has access to reasonably priced surgical care.
To that end, the clinic lists fixed costs for all of its major surgical specialities on its website, where it says clients should notice a significant reduction compared to other providers.
It also offers a 12-month post-surgical complications warranty.
Rob said: “Many pet-owners are unaware that there are three major companies which own the vast majority of veterinary practices in the UK.
"That is not necessarily of benefit to those using the services, as prices can rise when competition is low.
"Myself, Nick and Stuart felt very strongly that there was a different way to do things.
“No one becomes a vet to see animals suffer or pet-owners struggle to make tough financial decisions.
"We knew it was possible to offer a top quality service, with the best facilities and equipment available, whilst also keeping prices at a realistic level – and that is where the vision for Vita Referrals came from.
"We also wanted the freedom to offer collaborative decision-making, the removal of complex forms and bureaucracy and what we believe is an industry-leading 12-month complications guarantee on routine surgeries.
"It’s time there was more disruption and competition in the sector – and that will, ultimately, only be a good thing for pets, owners and vets.”
www.vitareferrals.co.uk
The VMD, which reclassified the product following a request from Zoetis, says that increasing the availability of this anthelmintic should help it to be incorporated into strategic worm control programmes on farms in line with best practice guidance on worm control. This could result in long term health benefits for sheep, for example by reducing the development and spread of anthelmintic resistance, thereby prolonging the effective use of anthelmintics.
However, both the British Veterinary Association and the Sheep Veterinary Society have expressed concerns over the move.
BVA Junior Vice President John Fishwick said: "We know that resistance to anthelmintics is increasing in grazing animals worldwide and needs to be addressed to avoid a potentially disastrous situation of being unable to tackle parasites. The reclassification of Startect Dual Active from POM-V to POM-VPS is in direct opposition to the trend in Europe, where we are seeing increased control over dispensing of anthelmintics in species where resistance is posing a serious threat to animal health, welfare and profitable production; we're extremely concerned that we might start seeing resistance develop in Group 4 as a result.
"BVA believes that the prescribing of anthelmintics requires a level of control best provided by a veterinary surgeon who has the animals under his/her care, and is based on a sound clinical diagnosis. The drugs are best used as part of a flock health plan drawn up by farmers in conjunction with their vet in order to protect animal health and welfare and safeguard the efficacy of these products for the future."
Sheep Veterinary Society President Kathryn Dun said: "Group 4 anthelmintics should be used only as part of a careful designed strategy for the individual farm and it is imperative that this strategy is worked out with a vet and is part of a flock health plan for that farm. The products need to be used, in the correct way, to help prolong the life of our other anthelmintics.
"We are unlikely to have any further new groups of anthelmintics in the foreseeable future, so education of those buying and selling these products is crucial to ensure the longevity of the effective action of them against sheep parasites."
Further information on BVA's policy on anthelmintics can be found here: www.bva.co.uk/news-campaigns-and-policy/policy/medicines/anthelmintics
76 vets, 34 nurses and 7 other practice staff took part in the survey, which was conducted at the VetsNow ECC Virtual Congress. Participants were asked a number of questions on antibiotic resistance and UTI management.
47% of vets said they currently feel confident prescribing antibiotics for suspected UTIs in the absence of culture and sensitivity results. However, 84% would be confident if they were able to use a rapid in-house sensitivity test.
77% of the participants said they were concerned about the increasing emergence of antimicrobial resistance.
Rachel Kirkby MRCVS, Business Development Director, said: "Antibiotic resistance is a huge threat to both human and animal healthcare across the world. We all need to work together to address it, and at Test and Treat we want to make it easier for vets in practice to do their bit by prescribing antibiotics according to best practice."
Test and Treat says the problem is that while many vets are keen to tackle resistance, it is not always easy to avoid empirical prescribing in practice. Of the vets surveyed, 65% reported that they are typically not able to obtain an accurate clinical diagnosis prior to prescribing antimicrobial therapy.
Rachel said: “It can be frustrating for vets to have to prescribe empirically when they don’t have any information on antibiotic sensitivity. But logistical constraints often mean that it’s not practical to send samples off to the lab.”
Test and Treat's U-Treat system consists of two rapid tests: a 5-minute assay that can confirm the presence of infection and a 30-minute assay that evaluates antibiotic sensitivity. With this diagnostic tool, vets can therefore select and prescribe the most appropriate antibiotic within an hour.
Rachel said: "Since you get results so quickly, you can use the test while the owner waits – or, in the current situation, more likely goes for a walk and comes back. This means that vets can get their patients started on the most appropriate treatment right away.”
U-Treat is currently validated for use in dogs and cats, but company says it is also looking to license it in rabbits and human healthcare.
To find out more about U-Treat, contact Test and Treat’s National Sales Manager Jo Nickerson on Jo.Nickerson@tandtreat.com or visit http://www.tandtreat.com.
Formerly known as BSAVA’s Scottish Congress, Alba delegates will be treated to 28 lectures, four practicals, ten hours of CPD and a commercial exhibition.
There are three lecture streams: one for vets, another for vet nurses and another open to all.
Highlights include ‘Echocardiology’ with Kieran Borgeat, ‘Dermatology: What can nurses do?’ with Sue Paterson, and ‘Wildlife Triage’ with Jenna Richardson.
The practical sessions are open to all and include sampling techniques, suturing and a ferret clinical exam.
There's a gala dinner on Friday 16th from 7:30pm, starting with a drinks reception, followed by dinner and entertainment in the evening, with a live band and ceilidh dancing.
Angela McLaughlin, Scottish Regional Chair at the BSAVA said: “We are delighted that we are returning to Scotland after three years away as this is a great event that allows vets and nurses the opportunity to improve their skills and knowledge, while visiting an idyllic part of the country!”
For BSAVA members, tickets cost £240 +VAT for vets, £165 +VAT for veterinary nurses, and £65 +VAT for students.
Day tickets and non-member tickets are also available.
There's an additional fee of £10 +VAT for all practical sessions.
Tickets for the gala dinner are £35 for delegates and £55 for guests.
If you are looking for somewhere to stay, BSAVA’s hotel booking partner, BCD Meetings & Events, can help.
www.bsavaevents.com/bsavaalba2022
Bayer Animal Health, maker of Advocate, has announced that it will be running its 'Be Lungworm Aware' campaign in April.
The company says the campaign aims to help raise awareness of Angiostrongylus vasorum amongst dog owners and support the veterinary practice as a source of further information. The initiative will be backed by a national TV and print advertising campaign. Media vet Joe Inglis will also be supporting the initiative and will be talking about Angiostrongylus vasorum during a series of radio and web broadcasts.
Bayer has produced new support materials, including an updated lungworm PR pack. The materials are designed to allow veterinary practices to educate owners on the disease, whilst helping to raise the profile of the practice in the local community.
Meanwhile, the research carried out by the company has revealed some interesting insights into dog owners' understanding of lungworm.
Despite awareness being fairly high with nearly half of owners claiming to know about the condition, 84% of this group did not know any of the clinical signs associated with the infection, while only 60% were aware that the disease could be fatal if left untreated. Understanding of how dogs become infected was also relatively low with only 24% of owners recognising the role of slugs and snails as the intermediate host for the parasite. As well as playing a vital role in alerting owners to the emergence of the disease, the veterinary practice was cited as the primary source of information that owners would refer to if they needed advice on treating this parasite.
Eric Morgan from the University of Bristol said: "Angiostrongylus vasorum appears to be continuing its spread to new locations in the UK. It is therefore important that dog owners are educated on the infection and the signs to look out for, to enable them to seek treatment before it is too late."
For further details, or to order the new practice materials, please contact your Bayer representative or ring 0845 2574798 quoting 'Be Lungworm Aware'.